Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Page revision history updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T20:15:52.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2; no substantive study details appear to have changed, To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T01:45:55.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-04T23:51:30.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added a 'Show glossary' option and updated the revision stamp to v3.4.0. Capitalization changes were made to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data', replacing the prior lowercase labels.
    Difference
    0.2%
    Check dated 2026-01-28T21:40:29.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision history shows addition of Revision: v3.3.4 and removal of Revision: v3.3.3. These are minor internal edits to the page’s revision history and do not affect study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:54:26.000Z thumbnail image
  8. Check
    83 days ago
    Change Detected
    Summary
    Added a centralized Locations section listing all participating sites by state (Alabama, Arizona, California, Colorado, Florida, Georgia, Idaho, Illinois, Kansas, Kentucky, Louisiana, Massachusetts, Missouri, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, Tennessee, Texas, Utah, Virginia, Washington). The previous per-state location headings were removed and the HHS Vulnerability Disclosure section was deleted.
    Difference
    2%
    Check dated 2025-12-23T22:31:41.000Z thumbnail image

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.